Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aurinia Pharm Ord (NQ: AUPH )

8.835 -0.025 (-0.28%)
Streaming Delayed Price Updated: 2:43 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aurinia Pharm Ord

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotech Conference
From Aurinia Pharmaceuticals Inc.
Via Business Wire
84 Biggest Movers From Friday
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 41.3% to close at $4.86 on Friday after the company inked an agreement with turnkey mining solutions provider Hertford... 
Via Benzinga
Analyzing Aurinia Pharmaceuticals's Unusual Options Activity
Aurinia Pharmaceuticals (NASDAQ:AUPH) shares experienced ... 
Via Benzinga
Mid-Afternoon Market Update: Dow Gains 140 Points; Spectrum Pharmaceuticals Shares Plummet
Toward the end of trading Friday, the Dow traded up 0.40% to 35,204.21 while the NASDAQ fell 0.41% to 14,833.72. The S&P also rose, gaining 0.16% to 4,435.97. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Aurinia Pharmaceuticals Stock Was Surging on Friday
Investors were relieved to see significant sales from the company's first commercial-stage drug. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Aurinia Pharmaceuticals Inc (AUPH) Q2 2021 Earnings Call Transcript
AUPH earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
From Aurinia Pharmaceuticals Inc.
Via Business Wire
Delta Outbreak
The US market was droopy because of poor private sector jobless numbers. 
Via Talk Markets
55 Stocks Moving In Friday's Mid-Day Session
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares jumped 29.9% to $4.47 after the company inked an agreement with turnkey mining solutions provider Hertford Advisors Ltd to provide a... 
Via Benzinga
Cramer Advises Viewers On Palantir, SoFi And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't understand why is MKS Instruments, Inc. (NASDAQ: MKSI) trading so cheap. He would be a buyer.... 
Via Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
88 Biggest Movers From Yesterday
Gainers BeyondSpring Inc. (NASDAQ: BYSI) shares climbed 176% to close at $26.58 on Wednesday in reaction to topline data from DUBLIN-3 Phase 3 trial evaluating plinabulin in... 
Via Benzinga
62 Biggest Movers From Yesterday
Gainers Flora Growth Corp. (NASDAQ: FLGC) surged 63.1% to close at $8.27. The Miami-based cannabis producer confirmed Tuesday it has signed a non-binding letter of intent to... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Understanding Aurinia Pharmaceuticals's Unusual Options Activity
On Wednesday, shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) saw unusual options activity. After the option alert, the stock price moved up to $12.55. Sentiment: BULLISH Option... 
Via Benzinga
Banned Merger
Today stock markets are in disarray after the full horror of Beijing's attack on Chinese capitalism has been understood. 
Via Talk Markets
Aurinia Pharmaceuticals to Release Second Quarter 2021 Financial Results on August 5, 2021
From Aurinia Pharmaceuticals Inc.
Via Business Wire
Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange
From Aurinia Pharmaceuticals Inc.
Via Business Wire
Aurinia Awards $250,000 in Grants to Support Patient Navigation Programs
From Aurinia Pharmaceuticals Inc.
Via Business Wire
Aurinia Announces Licensing Partner Otsuka Filed Initial Marketing Authorization Application (MAA) for Voclosporin with the European Medicines Agency (EMA)
From Aurinia Pharmaceuticals Inc.
Via Business Wire
Reconsidered Boom
The US markets tried to repeat the big rise from yesterday, and appears to have succeeded. 
Via Talk Markets
The First Day Of Summer And Prime Day
The bull is back in business today. 
Via Talk Markets
Two Rate Hikes In 2023
This afternoon our Fed chief Jerome Powell predicted there will be interest rate hikes faster than before. The news hit US stocks, gold, and bitcoin hard. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors
From Aurinia Pharmaceuticals Inc.
Via Business Wire
Wednesday News And Catch-Up
Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Aurinia Announces Results of the 2021 Annual General Meeting
From Aurinia Pharmaceuticals Inc.
Via Business Wire
Aurinia Announces Additional Analysis of its AURORA 1 Phase 3 Study Data Presented at ERA-EDTA 2021 Congress
From Aurinia Pharmaceuticals Inc.
Via Business Wire
Fan Hit
The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares. 
Via Talk Markets
Unusual Options Activity Insight: Aurinia Pharmaceuticals
Aurinia Pharmaceuticals (NASDAQ:AUPH) shares experienced unusual options activity on Thursday. The stock price moved down to $13.6 following the option alert. Sentiment: BEARISH... 
Via Benzinga
The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (... 
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-... 
Via Benzinga
Exposures Product Safety
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS